文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.

作者信息

Yu Xi, Li Shenglan, Ke Shuai, Ye Chenglin, Wang Qinghua, Wang Huaxin, Wang Lei

机构信息

Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.

Department of Radiography, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.

出版信息

J Cancer. 2024 Apr 19;15(11):3242-3253. doi: 10.7150/jca.94343. eCollection 2024.


DOI:10.7150/jca.94343
PMID:38817867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11134447/
Abstract

Bladder Cancer (BCa) is one of the most common cancers of the urinary system. Colony-stimulating factor 2 (CSF2) is involved in many cancers, but not BCa. We investigated the effect of CSF2 on BCa in this study and the underlying molecular mechanisms. CSF2 mRNA levels in BCa were analyzed using the Cancer Genome Atlas (TCGA) database. Western blot was conducted to verify CSF2 expression in BCa tissue samples and cell lines. The effect of CSF2 on the growth of BCa cells was assessed by CCK8 and colony formation. To determine the migration and invasion capabilities of BCa cells, transwell analysis and wound healing assays were conducted. Next, western blot was used to explore the underlying mechanism. In the end, a xenografted BCa mouse model was established to examine the effects of CSF2 on tumorigenesis . Results showed that CSF2 mRNA was upregulated in BCa samples. Knocking down CSF2 significantly inhibited the proliferation and tumorigenesis of BCa cells and . Mechanism analysis revealed that CSF2 knockdown inhibited the proliferation and invasion of BCa cells via AKT/mTOR signaling. Based on these results, CSF2 promotes the proliferation and tumorigenesis of BCa.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/c8ac6b5248c7/jcav15p3242g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a80a8f383cb7/jcav15p3242g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a6eb92ffd3bc/jcav15p3242g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/1595dba694fb/jcav15p3242g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/971bbef230a2/jcav15p3242g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/eda8111c22cb/jcav15p3242g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/3040061ec7c3/jcav15p3242g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/c8ac6b5248c7/jcav15p3242g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a80a8f383cb7/jcav15p3242g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a6eb92ffd3bc/jcav15p3242g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/1595dba694fb/jcav15p3242g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/971bbef230a2/jcav15p3242g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/eda8111c22cb/jcav15p3242g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/3040061ec7c3/jcav15p3242g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg

相似文献

[1]
CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.

J Cancer. 2024-4-19

[2]
HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.

Mol Genet Genomics. 2023-11

[3]
DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.

Cell Signal. 2023-2

[4]
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.

J Exp Clin Cancer Res. 2022-5-17

[5]
HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.

Mol Biol Rep. 2023-1

[6]
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer.

World J Surg Oncol. 2023-8-22

[7]
ID2 Inhibits Bladder Cancer Progression and Metastasis PI3K/AKT Signaling Pathway.

Front Cell Dev Biol. 2021-10-22

[8]
UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.

J Recept Signal Transduct Res. 2022-4

[9]
CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.

Cell Cycle. 2023-4

[10]
Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.

Folia Histochem Cytobiol. 2021

引用本文的文献

[1]
Epitranscriptomic mechanisms and implications of RNA mC modification in cancer.

Theranostics. 2025-7-25

[2]
CSF2 promotes chemoresistance in colorectal cancer by regulating Notch pathway.

Discov Oncol. 2025-4-9

[3]
CircPRKCA facilitates esophageal squamous cell carcinoma metastasis via m5C-dependent CSF2 mRNA stabilization.

J Transl Med. 2025-4-1

本文引用的文献

[1]
Cancer statistics, 2024.

CA Cancer J Clin. 2024

[2]
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.

Oncol Rep. 2022-7

[3]
Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation.

Front Pharmacol. 2021-10-29

[4]
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

Eur Urol. 2022-1

[5]
Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.

Int J Biol Sci. 2021-6-26

[6]
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.

Front Immunol. 2021

[7]
PSMD12 promotes glioma progression by upregulating the expression of Nrf2.

Ann Transl Med. 2021-4

[8]
Advances in bladder cancer biology and therapy.

Nat Rev Cancer. 2021-2

[9]
Hesperetin Promotes Cisplatin-Induced Apoptosis of Gastric Cancer and by Upregulating Expression.

Front Pharmacol. 2020-8-27

[10]
DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.

Cell Death Dis. 2020-8-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索